Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Personalis Inc (NQ: PSNL )

1.385 -0.015 (-1.07%)
Streaming Delayed Price Updated: 1:17 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,221
Open 1.360
Bid (Size) 1.380 (4)
Ask (Size) 1.390 (4)
Prev. Close 1.400
Today's Range 1.350 - 1.400
52wk Range 0.8906 - 2.600
Shares Outstanding 48,518,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
4 Analysts Have This To Say About Personalis
Via Benzinga
PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q1 2024
PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-32.11%
-32.11%
1 Month
+11.69%
+11.69%
3 Month
+4.92%
+4.92%
6 Month
+34.47%
+34.47%
1 Year
-33.09%
-33.09%

More News

Read More
Personalis Reports First Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Announce First Quarter 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Via Benzinga
Personalis: Q4 Earnings Insights
Via Benzinga
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
Via Benzinga
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Via Benzinga
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
From Personalis, Inc.
Via Business Wire
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
From Personalis, Inc.
Via Business Wire
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Via Benzinga
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
Via Benzinga
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Personalis, Inc.
Via Business Wire
Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
Via Benzinga
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
From Personalis, Inc.
Via Business Wire
Earnings Scheduled For February 28, 2024
Via Benzinga
Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Participate at Upcoming Investor Conferences
From Personalis, Inc.
Via Business Wire
Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
From Personalis, Inc.
Via Business Wire
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Personalis, Inc.
Via Business Wire
Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
From Personalis, Inc.
Via Business Wire
Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
From Personalis, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.